These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12196647)

  • 1. Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region.
    de Jong BA; Huizinga TW; Zanelli E; Giphart MJ; Bollen EL; Uitdehaag BM; Polman CH; Westendorp RG
    Neurology; 2002 Aug; 59(4):549-55. PubMed ID: 12196647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus.
    van der Linden MW; van der Slik AR; Zanelli E; Giphart MJ; Pieterman E; Schreuder GM; Westendorp RG; Huizinga TW
    Genes Immun; 2001 Nov; 2(7):373-80. PubMed ID: 11704803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
    Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
    BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.
    Haegert DG; Swift FV; Benedikz J
    Neurology; 1996 Apr; 46(4):1107-11. PubMed ID: 8780100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis.
    Sandberg-Wollheim M; Ciusani E; Salmaggi A; Pociot F
    Mult Scler; 1995 Nov; 1(3):181-5. PubMed ID: 9345451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3.
    Schotte H; Willeke P; Tidow N; Domschke W; Assmann G; Gaubitz M; Schlüter B
    Scand J Rheumatol; 2005; 34(2):114-21. PubMed ID: 16095006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-associated susceptibility to type 1 diabetes is caused by linkage disequilibrium with HLA-DR3 haplotypes.
    Kumar N; Kaur G; Tandon N; Mehra N
    Hum Immunol; 2012 May; 73(5):566-73. PubMed ID: 22366579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE.
    Graham RR; Ortmann W; Rodine P; Espe K; Langefeld C; Lange E; Williams A; Beck S; Kyogoku C; Moser K; Gaffney P; Gregersen PK; Criswell LA; Harley JB; Behrens TW
    Eur J Hum Genet; 2007 Aug; 15(8):823-30. PubMed ID: 17406641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.
    Barcellos LF; Oksenberg JR; Begovich AB; Martin ER; Schmidt S; Vittinghoff E; Goodin DS; Pelletier D; Lincoln RR; Bucher P; Swerdlin A; Pericak-Vance MA; Haines JL; Hauser SL;
    Am J Hum Genet; 2003 Mar; 72(3):710-6. PubMed ID: 12557126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
    Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
    Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2.
    Zipp F; Windemuth C; Pankow H; Dichgans J; Wienker T; Martin R; Müller C
    Hum Immunol; 2000 Oct; 61(10):1021-30. PubMed ID: 11082515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
    Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
    Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ.
    Aminkeng F; Van Autreve JE; Koeleman BP; Quartier E; Van Schravendijk C; Gorus FK; Van der Auwera BJ;
    Hum Immunol; 2007 Aug; 68(8):690-7. PubMed ID: 17678725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor microsatellites show association with multiple sclerosis.
    Kirk CW; Droogan AG; Hawkins SA; McMillan SA; Nevin NC; Graham CA
    J Neurol Sci; 1997 Mar; 147(1):21-5. PubMed ID: 9094056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFA promoter polymorphisms and narcolepsy.
    Wieczorek S; Gencik M; Rujescu D; Tonn P; Giegling I; Epplen JT; Dahmen N
    Tissue Antigens; 2003 Jun; 61(6):437-42. PubMed ID: 12823767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of HLA microsatellite marker in Tunisian pemphigus foliaceus.
    Abida O; Mahfoudh N; Kammoun A; Gaddour L; Hakim F; Toumi A; Masmoudi A; Ben Ayed M; Turki H; Masmoudi H; Makni H
    Hum Immunol; 2013 Jan; 74(1):104-9. PubMed ID: 23073295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.
    González-Enríquez GV; Torres-Mendoza BM; Márquez-Pedroza J; Macías-Islas MA; Ortiz GG; Cruz-Ramos JA
    Immunogenetics; 2018 Aug; 70(8):547-551. PubMed ID: 29397401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus.
    Rood MJ; van Krugten MV; Zanelli E; van der Linden MW; Keijsers V; Schreuder GM; Verduyn W; Westendorp RG; de Vries RR; Breedveld FC; Verweij CL; Huizinga TW
    Arthritis Rheum; 2000 Jan; 43(1):129-34. PubMed ID: 10643708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta.
    Villoslada P; Barcellos LF; Rio J; Begovich AB; Tintore M; Sastre-Garriga J; Baranzini SE; Casquero P; Hauser SL; Montalban X; Oksenberg JR
    J Neuroimmunol; 2002 Sep; 130(1-2):194-201. PubMed ID: 12225902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.
    Sospedra M; Muraro PA; Stefanová I; Zhao Y; Chung K; Li Y; Giulianotti M; Simon R; Mariuzza R; Pinilla C; Martin R
    J Immunol; 2006 Feb; 176(3):1951-61. PubMed ID: 16424227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.